Mira Pharmaceuticals (MIRA) Cash & Equivalents (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Cash & Equivalents of $6.35 million for the quarter ended Dec 31, 2025, up 124.0% from $2.83 million a year earlier and up 140.3% from the prior quarter.
Powered by 
Analysis
Mira Pharmaceuticals (MIRA) Cash & Equivalents (2022 - 2025) Analysis & Trends
Since the quarter ended Sep 30, 2022, Mira Pharmaceuticals has reported Cash & Equivalents for 13 quarters.
- Annual Cash & Equivalents shows a three-year compound annual growth rate of 162.5% (years ended Dec 2022 to Dec 2025).
- In prior years, Mira Pharmaceuticals' Cash & Equivalents was $2.83 million in the year ended Dec 31, 2024 (-38.4%), $4.6 million in the year ended Dec 31, 2023 and $350,978 in the year ended Dec 31, 2022.
- The figure for the quarter ended Dec 31, 2025 stands as the highest quarterly Cash & Equivalents in data going back to the quarter ended Sep 30, 2022.
- On a year-over-year basis, Cash & Equivalents increased in 1 of the last five quarters, with an average decline of 9.2%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $2.64 million (quarter ended Sep 30, 2025), $730,475 (quarter ended Jun 30, 2025) and $1.21 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Mira Pharmaceuticals | 14.69 Mn | -5.81 Mn | - | 6.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.35 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 730,475.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 4.14 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 4.60 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | 24,823.00 |
| Mar 31, 2023 | 1,349.00 |
| Dec 31, 2022 | 350,978.00 |
| Sep 30, 2022 | 187,415.00 |
| Jun 30, 2022 | 825,983.00 |
API Access
Mira Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MIRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();